SJS Investment Consulting’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7K Sell
99
-27
-21% -$1.95K ﹤0.01% 1538
2026
Q2
$9.41K Buy
126
+120
+2,000% +$8.64K ﹤0.01% 1104
2026
Q1
$428 Buy
6
+3
+100% +$205 ﹤0.01% 1792
2025
Q4
$178 Hold
3
– – ﹤0.01% 1838
2025
Q3
$166 Hold
3
– – ﹤0.01% 1504
2025
Q2
$130 Sell
3
-5
-63% -$193 ﹤0.01% 1450
2025
Q1
$317 Buy
8
+2
+33% +$89 ﹤0.01% 1368
2024
Q4
$245 Buy
6
+2
+50% +$83 ﹤0.01% 1433
2024
Q3
$156 Sell
4
-4
-50% -$159 ﹤0.01% 1537
2024
Q2
$350 Hold
8
– – ﹤0.01% 1399
2024
Q1
$382 Buy
8
+1
+14% +$45 ﹤0.01% 1368
2023
Q4
$331 Sell
7
-1
-13% -$42 ﹤0.01% 1356
2023
Q3
$381 Buy
8
+1
+14% +$55 ﹤0.01% 1306
2023
Q2
$408 Sell
7
-1
-13% -$60 ﹤0.01% 1226
2023
Q1
$573 Sell
8
-2
-20% -$159 ﹤0.01% 1105
2022
Q4
$704 Buy
10
+4
+67% +$282 ﹤0.01% 1097
2022
Q3
$0 Buy
+6
New +$403 ﹤0.01% 1372
2022
Q1
$0 Buy
+1
New +$67 ﹤0.01% 1128

Other funds holding NGVT

SJS Investment Consulting's NGVT Position: Q3 2026 in Review

SJS Investment Consulting reduced its Ingevity (NGVT) stake by 21% in Q3 2026, selling an estimated $1.95K and leaving 99 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

SJS Investment Consulting first reported a position in NGVT in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.41K in Q2 2026. 341 funds tracked by Wall St. Rank hold NGVT as of Q3 2026.

  • SJS Investment Consulting held 99 shares of Ingevity worth $7K as of Q3 2026.
  • SJS Investment Consulting sold 27 Ingevity shares in Q3 2026, an estimated $1.95K.
  • Ingevity made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1538 holding.
  • SJS Investment Consulting first reported a position in Ingevity in Q1 2022 and has held it in 18 quarters since.
  • SJS Investment Consulting's Ingevity position peaked at $9.41K in Q2 2026.
  • 341 funds tracked by Wall St. Rank held Ingevity as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.